Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 5

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Opportunities and impediments of human pluripotent stem cell-derived islets in the treatment of diabetes

Dadheech, Nidheesh, Cuesta-Gomez, Nerea, Jasra, Ila Tewari, Verhoeff, Kevin, Garza, Braulio Marfil, Mouhammed, Omar, Shapiro, A.M. James · 2022 · Journal of Immunology and Regenerative Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.regen.2022.100064

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 153

  1. Bommer, 2018, Global economic burden of diabetes in adults: projections from 2015 to 2030, Diabetes Care, 41, 963, 10.2337/dc17-1962 · DOI · Paper page
  2. Soumya D, 2011, Late stage complications of diabetes and insulin resistance, J Diabetes Metabol, 9
  3. Latres, 2019, Navigating two roads to glucose normalization in diabetes: automated insulin delivery devices and cell therapy, Cell Metabol, 29, 545, 10.1016/j.cmet.2019.02.007 · DOI
  4. Marfil-Garza, 2022, Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada, Lancet Diabetes Endocrinol., 10, 519, 10.1016/S2213-8587(22)00114-0 · DOI · Paper page
  5. Nair, 2020, Emerging routes to the generation of functional beta-cells for diabetes mellitus cell therapy, Nat Rev Endocrinol, 16, 506, 10.1038/s41574-020-0375-3 · DOI · Paper page
  6. Kerper, 2021, Pancreatic beta-cell development and regeneration, Cold Spring Harbor Perspect Biol
  7. Hussain, 2004, Stem-cell therapy for diabetes mellitus, Lancet, 364, 203, 10.1016/S0140-6736(04)16635-X · DOI
  8. Verhoeff, 2021, Inducible pluripotent stem cells as a potential cure for diabetes, Cells, 10, 10.3390/cells10020278 · DOI
  9. Rezania, 2014, Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells, Nat Biotechnol, 32, 1121, 10.1038/nbt.3033 · DOI · Paper page
  10. Millman, 2017, Autologous pluripotent stem cell-derived beta-like cells for diabetes cellular therapy, Diabetes, 66, 1111, 10.2337/db16-1406 · DOI
  11. D'Amour, 2006, Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells, Nat Biotechnol, 24, 1392, 10.1038/nbt1259 · DOI · Paper page
  12. Pagliuca, 2014, Generation of functional human pancreatic beta cells in vitro, Cell, 159, 428, 10.1016/j.cell.2014.09.040 · DOI · Paper page
  13. James Shapiro, 2021, Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device, Cell Rep Med, 2
  14. Velazco-Cruz, 2020, Advances toward engineering functionally mature human pluripotent stem cell-derived beta cells, Front Bioeng Biotechnol, 8, 786, 10.3389/fbioe.2020.00786 · DOI
  15. Melton, 2019, Advancing progress in stem cells and biomedicine: 2018-2019 Year in review, Stem Cell Rep, 12, 1179, 10.1016/j.stemcr.2019.05.019 · doi:10.1016/j.stemcr.2019.05.019
  16. Aghazadeh, 2021, View ORCID ProfileSara S. Nunes, M. Cristina Nostro. GP2-enriched pancreatic progenitors give rise to functional beta cells in vivo and eliminate the risk of teratoma formation, bioRxiv, 5
  17. Bruin, 2014, Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells, Stem Cell Res, 12, 194, 10.1016/j.scr.2013.10.003 · DOI · Paper page
  18. Jensen, 2021, Characterization of the nonendocrine cell populations in human embryonic stem cell-derived (hESC) islet-like clusters posttransplantation, Toxicol Pathol, 1926233211036395
  19. Martin, 1981, Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells, Proc Natl Acad Sci U S A, 78, 7634, 10.1073/pnas.78.12.7634 · DOI · Paper page
  20. Evans, 1981, Establishment in culture of pluripotential cells from mouse embryos, Nature, 292, 154, 10.1038/292154a0 · DOI · Paper page
  21. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  22. Liu, 2020, Advances in pluripotent stem cells: history, mechanisms, technologies, and applications, Stem Cell Rev Rep, 16, 3, 10.1007/s12015-019-09935-x · DOI · Paper page
  23. Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 · DOI · Paper page
  24. Odorico, 2001, Multilineage differentiation from human embryonic stem cell lines, Stem Cell, 19, 193, 10.1634/stemcells.19-3-193 · DOI · Paper page
  25. Caulfield, 2007, Informed consent in embryonic stem cell research: are we following basic principles?, CMAJ (Can Med Assoc J), 176, 1722, 10.1503/cmaj.061675 · doi:10.1503/cmaj.061675
  26. Zarzeczny, 2009, iPS cells: mapping the policy issues, Cell, 139, 1032, 10.1016/j.cell.2009.11.039 · DOI
  27. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  28. Malik, 2013, A review of the methods for human iPSC derivation, Methods Mol Biol, 997, 23, 10.1007/978-1-62703-348-0_3 · DOI · Paper page
  29. Sutherland, 1984, Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes, Trans Assoc Am Phys, 97, 80
  30. Sutherland, 1989, Recurrence of disease in pancreas transplants, Diabetes, 38, 85, 10.2337/diab.38.1.S85 · DOI · Paper page
  31. Liang, 2013, Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective, Cell Res, 23, 49, 10.1038/cr.2012.175 · DOI · Paper page
  32. Nichols, 2009, Naive and primed pluripotent states, Cell Stem Cell, 4, 487, 10.1016/j.stem.2009.05.015 · DOI · Paper page
  33. Takashima, 2014, Resetting transcription factor control circuitry toward ground-state pluripotency in human, Cell, 158, 1254, 10.1016/j.cell.2014.08.029 · DOI · Paper page
  34. Gu, 2016, Glycolytic metabolism plays a functional role in regulating human pluripotent stem cell state, Cell Stem Cell, 19, 476, 10.1016/j.stem.2016.08.008 · DOI · Paper page
  35. Qin, 2016, YAP induces human naive pluripotency, Cell Rep, 14, 2301, 10.1016/j.celrep.2016.02.036 · DOI · Paper page
  36. Tesar, 2016, Snapshots of pluripotency, Stem Cell Rep, 6, 163, 10.1016/j.stemcr.2015.12.011 · doi:10.1016/j.stemcr.2015.12.011
  37. Ying, 2008, The ground state of embryonic stem cell self-renewal, Nature, 453, 519, 10.1038/nature06968 · DOI · Paper page
  38. Davidson, 2015, The pluripotent state in mouse and human, Development, 142, 3090, 10.1242/dev.116061 · DOI
  39. Alexandrova, 2016, Selection and dynamics of embryonic stem cell integration into early mouse embryos, Development, 143, 24
  40. Chan, 2013, Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast, Cell Stem Cell, 13, 663, 10.1016/j.stem.2013.11.015 · DOI · Paper page
  41. Gafni, 2013, Derivation of novel human ground state naive pluripotent stem cells, Nature, 504, 282, 10.1038/nature12745 · DOI · Paper page
  42. Theunissen, 2014, Systematic identification of culture conditions for induction and maintenance of naive human pluripotency, Cell Stem Cell, 15, 471, 10.1016/j.stem.2014.07.002 · DOI · Paper page
  43. Irie, 2015, SOX17 is a critical specifier of human primordial germ cell fate, Cell, 160, 253, 10.1016/j.cell.2014.12.013 · DOI · Paper page
  44. Theunissen, 2016, Molecular criteria for defining the naive human pluripotent state, Cell Stem Cell, 19, 502, 10.1016/j.stem.2016.06.011 · DOI · Paper page
  45. Kiyokawa, 2020, Drug-induced naïve iPS cells exhibit better performance than primed iPS cells with respect to the ability to differentiate into pancreatic β-cell lineage, J Clin Med, 9, 10.3390/jcm9092838 · DOI
  46. Mayshar, 2010, Identification and classification of chromosomal aberrations in human induced pluripotent stem cells, Cell Stem Cell, 7, 521, 10.1016/j.stem.2010.07.017 · DOI · Paper page
  47. Hussein, 2011, Copy number variation and selection during reprogramming to pluripotency, Nature, 471, 58, 10.1038/nature09871 · DOI · Paper page
  48. Doss, 2019, Current challenges of iPSC-based disease modeling and therapeutic implications, Cells, 8, 10.3390/cells8050403 · DOI · Paper page
  49. Liu, 2017, The immunogenicity and immune tolerance of pluripotent stem cell derivatives, Front Immunol, 8, 645, 10.3389/fimmu.2017.00645 · DOI · Paper page
  50. Rouhani, 2016, Mutational history of a human cell lineage from somatic to induced pluripotent stem cells, PLoS Genet, 12, 10.1371/journal.pgen.1005932 · DOI
  51. Yamanaka, 2012, Induced pluripotent stem cells: past, present, and future, Cell Stem Cell, 10, 678, 10.1016/j.stem.2012.05.005 · DOI · Paper page
  52. Zhao, 2009, iPS cells produce viable mice through tetraploid complementation, Nature, 461, 86, 10.1038/nature08267 · DOI · Paper page
  53. Mikkelsen, 2008, Dissecting direct reprogramming through integrative genomic analysis, Nature, 454, 49, 10.1038/nature07056 · DOI · Paper page
  54. Chin, 2009, Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures, Cell Stem Cell, 5, 111, 10.1016/j.stem.2009.06.008 · DOI · Paper page
  55. Ghosh, 2010, Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells, PLoS One, 5, 10.1371/journal.pone.0008975 · DOI · Paper page
  56. Deng, 2009, Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming, Nat Biotechnol, 27, 353, 10.1038/nbt.1530 · DOI · Paper page
  57. Doi, 2009, Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts, Nat Genet, 41, 1350, 10.1038/ng.471 · DOI · Paper page
  58. Lister, 2011, Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells, Nature, 471, 68, 10.1038/nature09798 · DOI · Paper page
  59. Kim, 2011, Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells, Nat Biotechnol, 29, 1117, 10.1038/nbt.2052 · DOI · Paper page
  60. Ohi, 2011, Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells, Nat Cell Biol, 13, 541, 10.1038/ncb2239 · DOI · Paper page
  61. Guenther, 2010, Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells, Cell Stem Cell, 7, 249, 10.1016/j.stem.2010.06.015 · DOI · Paper page
  62. Newman, 2010, Lab-specific gene expression signatures in pluripotent stem cells, Cell Stem Cell, 7, 258, 10.1016/j.stem.2010.06.016 · DOI · Paper page
  63. Zhao, 2011, Immunogenicity of induced pluripotent stem cells, Nature, 474, 212, 10.1038/nature10135 · DOI · Paper page
  64. Deuse, 2019, De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans, Nat Biotechnol, 37, 1137, 10.1038/s41587-019-0227-7 · DOI
  65. Araki, 2013, Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells, Nature, 494, 100, 10.1038/nature11807 · DOI · Paper page
  66. Kaneko, 2013, To be immunogenic, or not to be: that's the iPSC question, Cell Stem Cell, 12, 385, 10.1016/j.stem.2013.03.008 · DOI
  67. Montini, 2006, Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration, Nat Biotechnol, 24, 687, 10.1038/nbt1216 · DOI · Paper page
  68. Mandai, 2017, Autologous induced stem-cell-derived retinal cells for macular degeneration, N Engl J Med, 376, 1038, 10.1056/NEJMoa1608368 · DOI · Paper page
  69. Li, 2016, Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain, Proc Natl Acad Sci U S A, 113, 6544, 10.1073/pnas.1605245113 · DOI · Paper page
  70. Meissner, 2008, Genome-scale DNA methylation maps of pluripotent and differentiated cells, Nature, 454, 766, 10.1038/nature07107 · DOI · Paper page
  71. Bhutani, 2010, Reprogramming towards pluripotency requires AID-dependent DNA demethylation, Nature, 463, 1042, 10.1038/nature08752 · DOI · Paper page
  72. Ban, 2011, Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors, Proc Natl Acad Sci U S A, 108, 14234, 10.1073/pnas.1103509108 · DOI · Paper page
  73. Sullivan, 2018, Quality control guidelines for clinical-grade human induced pluripotent stem cell lines, Regen Med, 13, 859, 10.2217/rme-2018-0095 · DOI · Paper page
  74. Nießing, 2021, Techno-economic analysis of automated iPSC production, Processes, 9, 240, 10.3390/pr9020240 · DOI
  75. Daniszewski, 2018, Automated cell culture systems and their applications to human pluripotent stem cell studies, SLAS Technol, 23, 315, 10.1177/2472630317712220 · DOI
  76. Rohani, 2020, Stirred suspension bioreactors maintain naive pluripotency of human pluripotent stem cells, Commun Biol, 3, 492, 10.1038/s42003-020-01218-3 · DOI
  77. Borys, B. S. et al. Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors. Stem Cell Res Ther 12, 55, doi:10.1186/s13287-020-02109-4(2021). · DOI
  78. Veres, 2019, Charting cellular identity during human in vitro beta-cell differentiation, Nature, 569, 368, 10.1038/s41586-019-1168-5 · DOI · Paper page
  79. Hogrebe, 2020, Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells, Nat Biotechnol, 38, 460, 10.1038/s41587-020-0430-6 · DOI · Paper page
  80. Velazco-Cruz, 2020, SIX2 regulates human beta cell differentiation from stem cells and functional maturation in vitro, Cell Rep, 31, 10.1016/j.celrep.2020.107687 · DOI
  81. Peterson, 2020, A method for the generation of human stem cell-derived alpha cells, Nat Commun, 11, 2241, 10.1038/s41467-020-16049-3 · DOI
  82. Sui, 2018, Pancreatic beta cell differentiation from human pluripotent stem cells, Curr Protoc Hum Genet, 99, e68, 10.1002/cphg.68 · DOI · Paper page
  83. Sui, 2021, Reduced replication fork speed promotes pancreatic endocrine differentiation and controls graft size, JCI Insight, 6, 10.1172/jci.insight.141553 · DOI · Paper page
  84. Stock, 2020, Conformal coating of stem cell-derived islets for β cell replacement in type 1 diabetes, Stem Cell Rep, 14, 91, 10.1016/j.stemcr.2019.11.004 · DOI · Paper page
  85. Yamanaka, 2020, Pluripotent stem cell-based cell therapy-promise and challenges, Cell Stem Cell, 27, 523, 10.1016/j.stem.2020.09.014 · DOI · Paper page
  86. Chung, 2006, Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation, J Neurochem, 97, 1467, 10.1111/j.1471-4159.2006.03841.x · DOI
  87. Huang, 2020, Signaling molecules regulating pancreatic endocrine development from pluripotent stem cell differentiation, Int J Mol Sci, 21, 10.3390/ijms21165867 · DOI
  88. Liu, 2020, Chromosomal aberration arises during somatic reprogramming to pluripotent stem cells, Cell Div, 15, 12, 10.1186/s13008-020-00068-z · DOI
  89. Okita, 2007, Generation of germline-competent induced pluripotent stem cells, Nature, 448, 313, 10.1038/nature05934 · DOI · Paper page
  90. Stadtfeld, 2008, Induced pluripotent stem cells generated without viral integration, Science, 322, 945, 10.1126/science.1162494 · DOI · Paper page
  91. Tokusumi, 2002, Recombinant Sendai viruses expressing different levels of a foreign reporter gene, Virus Res, 86, 33, 10.1016/S0168-1702(02)00047-3 · DOI
  92. Kroon, 2008, Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo, Nat Biotechnol, 26, 443, 10.1038/nbt1393 · DOI · Paper page
  93. Dadheech, 2019, Human induced pluripotent stem cells in the curative treatment of diabetes and potential impediments ahead, Adv Exp Med Biol, 1144, 25, 10.1007/5584_2018_305 · DOI
  94. Madrid, 2021, Autologous induced pluripotent stem cell-based cell therapies: promise, progress, and challenges, Curr Protoc, 1, e88, 10.1002/cpz1.88 · DOI
  95. Borys, 2020, Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors, Stem Cells Transl Med, 9, 1036, 10.1002/sctm.19-0406 · DOI · Paper page
  96. Huurman, 2008, Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation, PLoS One, 3, e2435, 10.1371/journal.pone.0002435 · DOI · Paper page
  97. Jaeger, 1997, Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts, Diabetes, 46, 1907, 10.2337/diab.46.11.1907 · DOI
  98. Piemonti, 2013, Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes, Diabetes, 62, 1656, 10.2337/db12-1258 · DOI
  99. Zhao, 2015, Humanized mice reveal differential immunogenicity of cells derived from autologous induced pluripotent stem cells, Cell Stem Cell, 17, 353, 10.1016/j.stem.2015.07.021 · DOI · Paper page
  100. Ruiz, 2012, Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells, Proc Natl Acad Sci U S A, 109, 16196, 10.1073/pnas.1202352109 · DOI · Paper page
  101. Pociot, 2016, Genetic risk factors for type 1 diabetes, Lancet, 387, 2331, 10.1016/S0140-6736(16)30582-7 · DOI · Paper page
  102. Pullen, 2018, Stem cell-derived pancreatic progenitor cells have now been transplanted into patients: report from IPITA 2018, Am J Transplant, 18, 1581, 10.1111/ajt.14954 · DOI
  103. van der Torren, 2017, Immunogenicity of human embryonic stem cell-derived beta cells, Diabetologia, 60, 126, 10.1007/s00125-016-4125-y · DOI
  104. Szot, 2015, Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm, Cell Stem Cell, 16, 148, 10.1016/j.stem.2014.12.001 · DOI
  105. Joshi, 2021, Modeling type 1 diabetes using pluripotent stem cell technology, Front Endocrinol, 12, 10.3389/fendo.2021.635662 · DOI
  106. Marfil-Garza, 2020, Current state and evidence of cellular encapsulation strategies in type 1 diabetes, Compr Physiol, 10, 839, 10.1002/j.2040-4603.2020.tb00139.x · DOI
  107. Ernst, 2019, Nanotechnology in cell replacement therapies for type 1 diabetes, Adv Drug Deliv Rev, 139, 116, 10.1016/j.addr.2019.01.013 · DOI
  108. Ernst, 2018, Islet encapsulation, J Mater Chem B, 6, 6705, 10.1039/C8TB02020E · DOI
  109. Korsgren, 2017, Islet encapsulation: physiological possibilities and limitations, Diabetes, 66, 1748, 10.2337/db17-0065 · DOI
  110. Bhatt, 2012, Tolerance-inducing strategies in islet transplantation, Internet J Endocrinol, 10.1155/2012/396524 · DOI
  111. Marfil-Garza, 2021, Progress in translational regulatory T cell therapies for type 1 diabetes and islet transplantation, Endocr Rev, 42, 198, 10.1210/endrev/bnaa028 · DOI
  112. Todo, 2016, A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation, Hepatology, 64, 632, 10.1002/hep.28459 · DOI · Paper page
  113. Sawitzki, 2020, Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials, Lancet, 395, 1627, 10.1016/S0140-6736(20)30167-7 · DOI · Paper page
  114. Harden, 2021, Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients, Am J Transplant, 21, 1603, 10.1111/ajt.16395 · DOI
  115. Ferreira, 2019, Next-generation regulatory T cell therapy, Nat Rev Drug Discov, 18, 749, 10.1038/s41573-019-0041-4 · DOI · Paper page
  116. Rodriguez-Barbosa, 2020, The role of TNFR2 and DR3 in the in vivo expansion of Tregs in T cell depleting transplantation regimens, Int J Mol Sci, 21, 10.3390/ijms21093347 · DOI
  117. Taylor, 2005, Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching, Lancet, 366, 2019, 10.1016/S0140-6736(05)67813-0 · DOI · Paper page
  118. Lanza, 2019, Engineering universal cells that evade immune detection, Nat Rev Immunol, 19, 723, 10.1038/s41577-019-0200-1 · DOI · Paper page
  119. Rong, 2014, An effective approach to prevent immune rejection of human ESC-derived allografts, Cell Stem Cell, 14, 121, 10.1016/j.stem.2013.11.014 · DOI · Paper page
  120. Shi, 2020, Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted β2m-HLA-G fusion proteins, Stem Cell, 38, 1423, 10.1002/stem.3269 · DOI
  121. Petersdorf, 2004, HLA matching in allogeneic stem cell transplantation, Curr Opin Hematol, 11, 386, 10.1097/01.moh.0000143701.88042.d9 · DOI
  122. Zhang, 2016, The importance of non-HLA antibodies in transplantation, Nat Rev Nephrol, 12, 484, 10.1038/nrneph.2016.88 · DOI · Paper page
  123. Bruin, 2015, Accelerated maturation of human stem cell-derived pancreatic progenitor cells into insulin-secreting cells in immunodeficient rats relative to mice, Stem Cell Rep, 5, 1081, 10.1016/j.stemcr.2015.10.013 · DOI
  124. Helman, 2021, A stem cell approach to cure type 1 diabetes, Cold Spring Harbor Perspect Biol, 13, 10.1101/cshperspect.a035741 · DOI
  125. Wang, 2009, Dependence of mouse embryonic stem cells on threonine catabolism, Science, 325, 435, 10.1126/science.1173288 · DOI · Paper page
  126. Shiraki, 2014, Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells, Cell Metabol, 19, 780, 10.1016/j.cmet.2014.03.017 · DOI · Paper page
  127. Nagashima, 2018, Selective elimination of human induced pluripotent stem cells using medium with high concentration of L-alanine, Sci Rep, 8, 10.1038/s41598-018-30936-2 · DOI
  128. Tateno, 2011, Glycome diagnosis of human induced pluripotent stem cells using lectin microarray, J Biol Chem, 286, 20345, 10.1074/jbc.M111.231274 · DOI · Paper page
  129. Tateno, 2015, Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein, Stem Cell Rep, 4, 811, 10.1016/j.stemcr.2015.02.016 · DOI
  130. Haramoto, 2020, A technique for removing tumourigenic pluripotent stem cells using rBC2LCN lectin, Regen Ther, 14, 306, 10.1016/j.reth.2020.03.017 · DOI
  131. Kuang, 2017, Efficient, selective removal of human pluripotent stem cells via ecto-alkaline phosphatase-mediated aggregation of synthetic peptides, Cell Chem Biol, 24, 685, 10.1016/j.chembiol.2017.04.010 · DOI
  132. Li, 2020, Single-cell RNA-seq reveals that CD9 is a negative marker of glucose-responsive pancreatic β-like cells derived from human pluripotent stem cells, Stem Cell Rep, 15, 1111, 10.1016/j.stemcr.2020.09.009 · DOI
  133. Nostro, 2015, Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines, Stem Cell Rep, 4, 591, 10.1016/j.stemcr.2015.02.017 · DOI · Paper page
  134. Liu, 1997, Design of polydactyl zinc-finger proteins for unique addressing within complex genomes, Proc Natl Acad Sci U S A, 94, 5525, 10.1073/pnas.94.11.5525 · DOI · Paper page
  135. Sanjana, 2012, A transcription activator-like effector toolbox for genome engineering, Nat Protoc, 7, 171, 10.1038/nprot.2011.431 · DOI · Paper page
  136. Mali, 2013, RNA-guided human genome engineering via Cas9, Science, 339, 823, 10.1126/science.1232033 · DOI · Paper page
  137. Brookhouser, 2017, May I cut in? Gene editing approaches in human induced pluripotent stem cells, Cells, 6, 10.3390/cells6010005 · DOI
  138. Martin, 2020, Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards, Nat Commun, 11, 2713, 10.1038/s41467-020-16455-7 · DOI
  139. Kim, 2011, High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice, PLoS One, 6
  140. Martin, 2019, Highly efficient and marker-free genome editing of human pluripotent stem cells by CRISPR-cas9 RNP and AAV6 donor-mediated homologous recombination, Cell Stem Cell, 24, 821, 10.1016/j.stem.2019.04.001 · DOI · Paper page
  141. Yabe, 2017, Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells, J Diabetes, 9, 168, 10.1111/1753-0407.12400 · DOI
  142. Balboa, 2021, Functional, metabolic and transcriptional maturation of stem cell derived beta cells, bioRxiv
  143. Mfopou, 2010, Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells, Gastroenterology, 138, 10.1053/j.gastro.2010.02.056 · DOI · Paper page
  144. D'Amour, 2005, Efficient differentiation of human embryonic stem cells to definitive endoderm, Nat Biotechnol, 23, 1534, 10.1038/nbt1163 · DOI · Paper page
  145. Rukstalis, 2009, Neurogenin3: a master regulator of pancreatic islet differentiation and regeneration, Islets, 1, 177, 10.4161/isl.1.3.9877 · DOI
  146. Aiello, 2014, Thyroid hormones promote endocrine differentiation at expenses of exocrine tissue, Exp Cell Res, 322, 236, 10.1016/j.yexcr.2014.01.030 · DOI
  147. Aguayo-Mazzucato, 2013, Thyroid hormone promotes postnatal rat pancreatic β-cell development and glucose-responsive insulin secretion through MAFA, Diabetes, 62, 1569, 10.2337/db12-0849 · DOI
  148. Kanak, 2014, Inflammatory response in islet transplantation, Internet J Endocrinol, 10.1155/2014/451035 · DOI
  149. Bellin, 2014, Defective glucagon secretion during hypoglycemia after intrahepatic but not nonhepatic islet autotransplantation, Am J Transplant, 14, 1880, 10.1111/ajt.12776 · DOI
  150. Gupta, 1997, The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined, Diabetes, 46, 28, 10.2337/diab.46.1.28 · DOI
  151. Addison, 2020, Considerations for an alternative site of islet cell transplantation, J Diabetes Sci Technol, 14, 338, 10.1177/1932296819868495 · DOI
  152. Pettis, 2019, Subcutaneous insulin administration: sufficient progress or ongoing need?, J Diabetes Sci Technol, 13, 3, 10.1177/1932296818817011 · DOI
  153. Fukuda, 2019, The intraperitoneal space is more favorable than the subcutaneous one for transplanting alginate fiber containing iPS-derived islet-like cells, Regen Ther, 11, 65, 10.1016/j.reth.2019.05.003 · DOI

Cited by

See all 5

Metadata

Authors
Dadheech, N., Cuesta-Gomez, N., Jasra, I. T., Verhoeff, K., Garza, B. M., Mouhammed, O., & Shapiro, A. M. J.
Venue
Journal of Immunology and Regenerative Medicine
Publisher
Elsevier BV
Published
2022-08
Volume
17
Pages
100064
ISSN
2468-4988
Cited by
5
References
25
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Opportunities and impediments of human pluripotent stem cell-derived islets in the treatment of diabetes. https://app.cochat.ai/papers/10.1016/j.regen.2022.100064
The paper
Dadheech, N., Cuesta-Gomez, N., Jasra, I. T., Verhoeff, K., Garza, B. M., Mouhammed, O., & Shapiro, A. M. J. (2022). Opportunities and impediments of human pluripotent stem cell-derived islets in the treatment of diabetes. Journal of Immunology and Regenerative Medicine. https://doi.org/10.1016/j.regen.2022.100064

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.